Tara Gomes


Scientist, Li Ka Shing Knowledge Institute


Tara Gomes an epidemiologist and a Principal Investigator of the Ontario Drug Policy Research Network (ODPRN), a provincial network of researchers with expertise in pharmaceutical utilization, outcomes and policy with the key objective of rapidly conducting relevant pharmacoepidemiology research for provincial decision-makers to inform drug policy in Ontario. She is also a Scientist in the Li Ka Shing Knowledge Institute of St. Michael’s Hospital and the Institute for Clinical Evaluative Sciences and an assistant professor at the University of Toronto in both the Leslie Dan Faculty of Pharmacy and the Institute of Health Policy Management and Evaluation. Her research is focused on pharmacoepidemiology, drug safety and drug policy research leveraging large, administrative databases, and she has published over 100 peer-reviewed articles and over 50 policy reports in this area.

She has worked closely with the Ontario Ministry of Health and Long-Term Care to develop evidence to inform policies related to opioid use and abuse in Ontario and has served as an expert for the United States Food and Drug Administration and the United States Department of Transportation in discussions related to opioid policies and regulations. In 2014, the ODPRN was recognized for the impact of their contributions in the field of Health and Education with the Institute for Public Administration of Canada’s Bronze Public Sector Leadership Award.

Recent Publications

  1. Quinn, KL, Macdonald, EM, Gomes, T, Mamdani, MM, Huang, A, Juurlink, DN et al.. Macrolides, Digoxin Toxicity and the Risk of Sudden Death: A Population-Based Study. Drug Saf. 2017; :. doi: 10.1007/s40264-017-0539-9. PubMed PMID:28421551 .
  2. Brown, HK, Ray, JG, Wilton, AS, Lunsky, Y, Gomes, T, Vigod, SN et al.. Association Between Serotonergic Antidepressant Use During Pregnancy and Autism Spectrum Disorder in Children. JAMA. 2017;317 (15):1544-1552. doi: 10.1001/jama.2017.3415. PubMed PMID:28418480 .
  3. Kwok, H, Khuu, W, Fernandes, K, Martins, D, Tadrous, M, Singh, S et al.. Impact of Unrestricted Access to Pregabalin on the Use of Opioids and Other CNS-Active Medications: A Cross-Sectional Time Series Analysis. Pain Med. 2017; :. doi: 10.1093/pm/pnw351. PubMed PMID:28340102 .
  4. Zipursky, JS, Macdonald, EM, Luo, J, Gomes, T, Mamdani, MM, Paterson, JM et al.. Lipophilic β-Blockers and Suicide in the Elderly. J Clin Psychopharmacol. 2017;37 (3):381-384. doi: 10.1097/JCP.0000000000000695. PubMed PMID:28338548 .
  5. Antoniou, T, Macdonald, EM, Yao, Z, Hollands, S, Gomes, T, Tadrous, M et al.. Association between statin use and ischemic stroke or major hemorrhage in patients taking dabigatran for atrial fibrillation. CMAJ. 2017;189 (1):E4-E10. doi: 10.1503/cmaj.160303. PubMed PMID:28246253 PubMed Central PMC5224945.
  6. Xu, Y, Schulman, S, Dowlatshahi, D, Holbrook, AM, Simpson, CS, Shepherd, LE et al.. Direct oral anticoagulant- or warfarin-related major bleeding: characteristics, reversal strategies and outcomes from a multi-center observational study. Chest. 2017; :. doi: 10.1016/j.chest.2017.02.009. PubMed PMID:28219635 .
  7. Knowles, SR, Lee, K, Paterson, JM, Shah, BR, Mamdani, MM, Juurlink, DN et al.. Self-Monitoring of Blood Glucose: Impact of Quantity Limits in Public Drug Formularies on Provincial Costs Across Canada. Can J Diabetes. 2017;41 (2):138-142. doi: 10.1016/j.jcjd.2016.08.225. PubMed PMID:27989494 .
  8. Fernandes, K, Martins, D, Juurlink, D, Mamdani, M, Paterson, JM, Spooner, L et al.. High-Dose Opioid Prescribing and Opioid-Related Hospitalization: A Population-Based Study. PLoS ONE. 2016;11 (12):e0167479. doi: 10.1371/journal.pone.0167479. PubMed PMID:27973601 PubMed Central PMC5156349.
  9. Gomes, T, Martins, D, Tadrous, M, Paterson, JM, Shah, BR, Tu, JV et al.. Association of a Blood Glucose Test Strip Quantity-Limit Policy With Patient Outcomes: A Population-Based Study. JAMA Intern Med. 2017;177 (1):61-66. doi: 10.1001/jamainternmed.2016.6851. PubMed PMID:27820619 .
  10. Tadrous, M, Martins, D, Yao, Z, Mamdani, MM, Juurlink, DN, Gomes, T et al.. Varenicline and Risk of Self-Harm: A Nested Case-Control Study. PLoS ONE. ;11 (9):e0163681. doi: 10.1371/journal.pone.0163681. PubMed PMID:27662654 PubMed Central PMC5035025.
Search PubMed

Affiliations & Other Activities

  • Assistant Professor, Leslie Dan Faculty of Pharmacy, University of Toronto
  • Assistant Professor, Institute for Health Policy, Management and Evaluation, University of Toronto
  • Scientist, Institute for Clinical Evaluative Sciences
  • Principal Investigator, Ontario Drug Policy Research Network